AZN
Price
$73.76
Change
+$0.23 (+0.31%)
Updated
Sep 26 closing price
Capitalization
228.48B
40 days until earnings call
AZNCF
Price
$146.16
Change
-$3.59 (-2.40%)
Updated
Sep 26 closing price
Capitalization
228.48B
Interact to see
Advertisement

AZN vs AZNCF

Header iconAZN vs AZNCF Comparison
Open Charts AZN vs AZNCFBanner chart's image
AstraZeneca
Price$73.76
Change+$0.23 (+0.31%)
Volume$4.35M
Capitalization228.48B
AstraZeneca
Price$146.16
Change-$3.59 (-2.40%)
Volume$944
Capitalization228.48B
AZN vs AZNCF Comparison Chart in %
Loading...
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AZNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZN vs. AZNCF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZN is a Buy and AZNCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (AZN: $73.76 vs. AZNCF: $146.16)
Brand notoriety: AZN: Notable vs. AZNCF: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 95% vs. AZNCF: 21%
Market capitalization -- AZN: $228.48B vs. AZNCF: $228.48B
AZN [@Pharmaceuticals: Major] is valued at $228.48B. AZNCF’s [@Pharmaceuticals: Major] market capitalization is $228.48B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $649.52B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 1 FA rating(s) are green whileAZNCF’s FA Score has 1 green FA rating(s).

  • AZN’s FA Score: 1 green, 4 red.
  • AZNCF’s FA Score: 1 green, 4 red.
According to our system of comparison, AZN is a better buy in the long-term than AZNCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 5 TA indicator(s) are bullish while AZNCF’s TA Score has 4 bullish TA indicator(s).

  • AZN’s TA Score: 5 bullish, 5 bearish.
  • AZNCF’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AZN is a better buy in the short-term than AZNCF.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а -3.30% price change this week, while AZNCF (@Pharmaceuticals: Major) price change was -5.32% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.20%. For the same industry, the average monthly price growth was -0.44%, and the average quarterly price growth was +12.50%.

Reported Earning Dates

AZN is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.20% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZN($228B) and AZNCF($228B) have the same market capitalization . AZN (27.78) and AZNCF (27.53) have similar P/E ratio . AZN YTD gains are higher at: 14.978 vs. AZNCF (12.431). AZN (16.8B) and AZNCF (16.8B) have comparable annual earnings (EBITDA) . AZN (7.11B) and AZNCF (7.11B) have equal amount of cash in the bank . AZN (32.8B) and AZNCF (32.8B) have identical debt. AZN (56.5B) and AZNCF (56.5B) have equivalent revenues.
AZNAZNCFAZN / AZNCF
Capitalization228B228B100%
EBITDA16.8B16.8B100%
Gain YTD14.97812.431120%
P/E Ratio27.7827.53101%
Revenue56.5B56.5B100%
Total Cash7.11B7.11B100%
Total Debt32.8B32.8B100%
FUNDAMENTALS RATINGS
AZN vs AZNCF: Fundamental Ratings
AZN
AZNCF
OUTLOOK RATING
1..100
5484
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
21
Undervalued
PROFIT vs RISK RATING
1..100
4558
SMR RATING
1..100
4646
PRICE GROWTH RATING
1..100
6059
P/E GROWTH RATING
1..100
8180
SEASONALITY SCORE
1..100
6585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZNCF's Valuation (21) in the null industry is in the same range as AZN (22) in the Pharmaceuticals Major industry. This means that AZNCF’s stock grew similarly to AZN’s over the last 12 months.

AZN's Profit vs Risk Rating (45) in the Pharmaceuticals Major industry is in the same range as AZNCF (58) in the null industry. This means that AZN’s stock grew similarly to AZNCF’s over the last 12 months.

AZN's SMR Rating (46) in the Pharmaceuticals Major industry is in the same range as AZNCF (46) in the null industry. This means that AZN’s stock grew similarly to AZNCF’s over the last 12 months.

AZNCF's Price Growth Rating (59) in the null industry is in the same range as AZN (60) in the Pharmaceuticals Major industry. This means that AZNCF’s stock grew similarly to AZN’s over the last 12 months.

AZNCF's P/E Growth Rating (80) in the null industry is in the same range as AZN (81) in the Pharmaceuticals Major industry. This means that AZNCF’s stock grew similarly to AZN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNAZNCF
RSI
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 7 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 3 days ago
69%
Momentum
ODDS (%)
Bearish Trend 3 days ago
42%
Bearish Trend 3 days ago
55%
MACD
ODDS (%)
Bearish Trend 3 days ago
43%
Bearish Trend 3 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
44%
Bearish Trend 3 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
42%
Bearish Trend 3 days ago
54%
Advances
ODDS (%)
Bullish Trend 26 days ago
55%
Bullish Trend 7 days ago
66%
Declines
ODDS (%)
Bearish Trend 4 days ago
43%
Bearish Trend 5 days ago
49%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
78%
Aroon
ODDS (%)
Bullish Trend 3 days ago
44%
Bullish Trend 3 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AZNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HONDU19.501.50
+8.33%
HCM II Acquisition Corp
MAGN11.030.58
+5.55%
Magnera Corporation
VECO29.870.42
+1.43%
Veeco Instruments
LEVI23.020.21
+0.92%
Levi Strauss & Co
NXTT22.52N/A
N/A
Next Technology Holding Inc

AZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZN has been loosely correlated with GSK. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZN
1D Price
Change %
AZN100%
+0.31%
GSK - AZN
62%
Loosely correlated
+0.84%
NVS - AZN
61%
Loosely correlated
+1.16%
SNY - AZN
48%
Loosely correlated
+1.04%
PFE - AZN
45%
Loosely correlated
+0.68%
LLY - AZN
41%
Loosely correlated
+1.39%
More

AZNCF and

Correlation & Price change

A.I.dvisor tells us that AZNCF and BAYRY have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AZNCF and BAYRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZNCF
1D Price
Change %
AZNCF100%
-2.40%
BAYRY - AZNCF
20%
Poorly correlated
+0.25%
AZN - AZNCF
16%
Poorly correlated
+0.31%
ABBV - AZNCF
9%
Poorly correlated
+0.95%
ALPMY - AZNCF
9%
Poorly correlated
-0.16%
ALPMF - AZNCF
7%
Poorly correlated
+0.91%
More